Human CellExp™Flt-3 / Flk-2, Fc Tag, Human Recombinant

(No reviews yet) Write a Review
SKU:
26-P1459
Availability:
Usually Shipped in 5 Working Days
Storage Temperature:
-20°C
Shipping Conditions:
Gel Pack
Shelf Life:
12 months
€179.00 - €536.00
Frequently bought together:

Description

Biomolecule/Target: N/A

Synonyms: Flt-3, Flk-2, STK-1, CD135, FLK2, FLT-3

Alternates names: Flt-3, Flk-2, STK-1, CD135, FLK2, FLT-3

Taglines: A member of a small family of growth factors that stimulate the proliferation of hematopoietic cells

Taglines: USA

Country of Animal Origin: USA

NCBI Gene ID #.: 2323

NCBI Gene Symbol: FLT3LG

Gene Source: Human

Accession #: P36888-1

Recombinant: True

Source: HEK 293 cells

Purity by SDS-PAGE #: >95%

Assay: SDS-PAGE

Purity: N/A

Assay #2: N/A

Endotoxin Level: Less than 1.0 EU per μg by the LAL method.

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: This protein carries a human IgG1 Fc tag at the C-terminus. The protein has a calculated MW of 84.8 kDa. The protein migrates as 110-120 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Concentration: N/A

Appearance: Lyophilized protein

Physical form description: Lyophilized

Reconstitution Instructions: Reconstitute in sterile deionized water to the desired protein concentration.

Background Information: Flt-3(Receptor-type tyrosine-protein kinase FLT3) is also known as FLK-2(Fetal liver kinase-2), STK-1(Stem cell tyrosine kinase 1), CD135. FLT3 is a cytokine receptor which belongs to the receptor tyrosine kinase class III. Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways.

Amino acid sequence: Asn 27 - Ser 543

Handling: Centrifuge the vial prior to opening.

Usage: N/A

View AllClose